Forbes April 9, 2024
Topline
Popular diabetes and weight loss drugs like Ozempic and Wegovy, known as GLP-1 medications, were not found to cause a substantial increase in the risk of developing thyroid cancer, according to one of the biggest studies to explore the link, which is the latest research to dive into the highly debated topic.
Key Facts
Crucial Quote
“Our study covers a broad group of patients and provides strong support that GLP-1 analogues are not associated with an increased risk of thyroid cancer,” Björn Pasternak, study author and principal researcher at the Department of Medicine, Solna, at Karolinska Institutet in Sweden, said in a statement.
Contra
Some studies have found GLP-1 drugs may cause thyroid cancer in humans. Researchers looking at...
Today's Sponsors
Today's Sponsor